The panel details the clinical and economic burden when patients switch between agents in plaque psoriasis.
Bhavesh Shah, PharmD
Advertisement
Articles by Bhavesh Shah, PharmD
Bhavesh Shah, PharmD, and Robert Groves, MD, discuss the priorities payers should be taking into account when managing psoriasis treatment.
Advertisement
Latest Updated Articles
Impact of Switching Agents in Plaque PsoriasisDecember 1st 2021
Utilization Management in PsoriasisDecember 1st 2021
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5